Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Transient global amnesia revealing multiple sclerosis.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions.
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
[Future challenges in multiple sclerosis].
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.
Psychological well-being in people with multiple sclerosis in an Iranian population.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
Restless legs syndrome as the initial presentation of multiple sclerosis.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.

Pages